(13 December 2023) On 30 November 2023, the 2023 Forbes China ESG Innovative Enterprises Selection Summit and Award Ceremony Dinner was held in Shenzhen. Fosun International was rated as “2023 Forbes China ESG Innovative Enterprise” for its excellent performance in corporate growth, ESG practices, execution capability for innovation and industry influence.The rate

The Inaugural Fosun Health Conference on Guangdong-Hong Kong-Macao Healthcare Development Integration was successfully held in Hong Kong by Fosun Health on 12 December 2023. With the background of integrating medical services of Guangdong, Hong Kong and Macao, this year’s conference themed “Collaboration and Integration for Better Healthcare” aimed to facilitate bette

Shanghai, China, 12 December 2023 – Shanghai Henlius Biotech, Inc. (2696.HK) announced that the NDA for new indication of HANSIZHUANG, serplulimab, an innovative anti-PD-1 mAb independently developed by the company, in combination with chemotherapy as a first-line treatment for patients with locally advanced or metastatic non-squamous non-small cell lung can

The “Dual Carbon Goal ActivistsConference 2023” was organized and held by Southern Weeklyin Beijingon 7 December 2023. The event focused on companies’ progress in the implementation of their strategies for achieving the dual goal of carbon emission peak and carbon neutrality (“dual carbon goal”) and identified the leaders and innovators in the dual-carbon goal

On 23 November 2023, the results of the fifth ESG Leading Enterprise Awards 2023, which was organized by the Chinese Edition of Bloomberg Businessweek in partnership with Deloitte, one of the world's largest accounting firms, and with the support from InvestHK under theGovernment of theHong Kong Special Administrative Region, Hong Kong Institute of Bankers

(Lisbon, 28 November 2023) Today Sustainalytics assigned an ESG rating of 11.7, Low Risk, to Fidelidade – Companhia deSeguros, S.A..This result places Fidelidade as the fourth best rated insurance company in the world (out of 301ranked by Sustainalytics) and the second among European insurers.The new rating represents a significant improvement compared to last year’s

Shanghai, China, November 23, 2023 – Shanghai Henlius Biotech, Inc. (2696. HK) announced that the investigational new drug (IND) applicationof HLX42 for Injection, the ADC product that developed by the company based on the collaboration with MediLink Therapeutics, has been approved by the U.S. Food and Drug Administration (FDA), for the treatment of adv

(23 November 2023, Hong Kong) Fosun International Limited (HKEX stock code: 00656) recently received “Excellence in Environmental Positive Impact Commendation” at the Hong Kong ESG Reporting Awards 2023, in recognition of the company’s active green management practices and contribution to environmental protection locally and globally.The Hong Kong ESG Reporting Awards

The 2023 Conference on the Development of China's Pharmaceutical Industry, co-sponsored by the Ministry of Industry and Information Technology, Beijing Municipal People's Government, National Health Commission, State-owned Assets Supervision and Administration Commission of the State Council, National Administration of Traditional Chinese Medicine&